Communiqués

16:01 Managers' transactions - Anat Loewenstein AQ
16:01 Managers' transactions - Marc Abitbol AQ
16:01 Managers' transactions - Heli Lindfors AQ
16:01 Managers' transactions - Bill Östman AQ
16:01 Managers' transactions - Charles Vilgrain AQ
16:01 Managers' transactions - Arne Boye Nielsen AQ
16:01 Managers' transactions - Nicklas Hansen AQ
16:01 Changes in Revenio Group Corporation's own shares AQ
11:30 INSIDE INFORMATION: Revenio Group Corporation announces the terms and conditions of its fully underwritten rights offering of approximately EUR 80 million AQ
15/09 Revenio updates its strategy for 2027–2029 and provides new financial targets for the strategy period AQ
14/09 Composition of Revenio’s Shareholders’ Nomination Board AQ
14/09 Revenio Oyj : Composition of Revenio's Shareholders' Nomination Board PU
10/09 ICare IC1000™: Precision Made Effortless AQ
08/09 Revenio Group Corporation: Half-Year Report January 1 - June 30, 2026 PU
08/09 Revenio Group Corporation: Half-Year Report January 1 – June 30, 2026 AQ
03/09 Revenio Group – Consensus estimates Q2 2026 AQ
27/08 Revenio Oyj : Half-year report January-June 2026 to be published on September 8, 2026 PU
27/08 Revenio’s Half-year report January-June 2026 to be published on September 8, 2026 AQ
20/08 Revenio Oyj : Invitation to Revenio Group's Capital Markets Day 2026 PU
20/08 Invitation to Revenio Group’s Capital Markets Day 2026 AQ
17/08 Revenio Oyj : iCare DRSplus included in FDA-cleared AI solution for diabetic retinopathy screening PU
17/08 Revenio’s iCare DRSplus included in FDA-cleared AI solution for diabetic retinopathy screening AQ
12/08 Jukka Kainulainen starts as Revenio CFO on August 24, 2026 AQ
06/08 Revenio Group’s iCare and EyeCheq announce strategic partnership and minority investment AQ
05/08 Revenio’s updated Disclosure Policy is published AQ
Aucun résultat pour cette recherche
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT